JMP Securities Downgrades Syros Pharmaceuticals (SYRS) to Market Perform Nov 13, 2024 02:57AM
JMP Securities Reiterates Market Outperform Rating on Syros Pharmaceuticals (SYRS) Jun 25, 2024 04:08PM
Syros to Participate in Upcoming Investor Conferences May 7, 2024 09:00AM
Syros Pharmaceuticals (SYRS) Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine Dec 6, 2023 07:03AM
Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine Dec 6, 2023 07:00AM


Nov 21, 2023 07:30AM Syros to Participate in Upcoming Investor Conferences
May 9, 2023 07:00AM Syros to Present at JMP Securities 2023 Life Sciences Conference
Jun 8, 2022 07:30AM Syros to Present at JMP Securities Life Sciences Conference
Nov 16, 2021 07:30AM Syros to Participate in Upcoming Investor Conferences
Jun 9, 2021 08:01AM Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference
Jan 20, 2021 06:22AM Syros Pharmaceuticals (SYRS) Prices 5.4M Share Common Offering at $14/Sh
Jan 19, 2021 10:41PM Syros Announces Pricing of $75.6 Million Public Offering of Common Stock
Aug 6, 2020 01:24PM Syros Pharmaceuticals (SYRS) PT Raised to $20 at JMP Securities, Following Earnings
Jun 17, 2020 08:00AM Syros Announces Change to Presentation Time at JMP Securities Hematology and Oncology Forum
Jun 11, 2020 08:31AM Syros to Present Virtually at JMP Securities Hematology and Oncology Forum
Jun 12, 2019 08:01AM Syros to Present at JMP Securities Life Sciences Conference
Apr 9, 2019 04:01PM Syros Announces Closing of Concurrent Public Offerings
Apr 5, 2019 07:16AM Syros Pharmaceuticals (SYRS) Announces Pricing of $70 Million Concurrent Public Offerings
Apr 5, 2019 07:15AM Syros Announces Pricing of $70 Million Concurrent Public Offerings
Apr 4, 2019 04:19PM Syros Pharmaceuticals (SYRS) Proposed Concurrent Offerings of Common Stock with Warrants and Preferred Stock with Warrants
Apr 4, 2019 04:18PM Syros Announces Proposed Concurrent Public Offerings of Common Stock with Warrants to Purchase Common Stock and Preferred Stock with Warrants to Purchase Common Stock
Mar 8, 2019 03:18AM JMP Securities Transfers Coverage on Syros Pharmaceuticals (SYRS) at Market Outperform
May 30, 2018 08:01AM Syros to Present at Upcoming Investor Conferences
Mar 12, 2018 07:03AM Syros Pharmaceuticals (SYRS) Names Joseph J. Ferra as Chief Financial Officer
Mar 12, 2018 07:00AM Syros Announces Appointment of Joseph J. Ferra as Chief Financial Officer
Jan 31, 2018 05:44AM Syros Pharmaceuticals (SYRS) Prices 4.19M Share Common Offering at $9.55/Sh
Jan 30, 2018 04:12PM Syros Pharmaceuticals (SYRS) Announces Proposed $40M Offering of Common Stock
Sep 28, 2017 04:40AM JMP Securities Upgrades Syros Pharmaceuticals (SYRS) to Market Outperform
Aug 10, 2017 05:01AM JMP Securities Downgrades Syros Pharmaceuticals (SYRS) to Market Perform
Jun 13, 2017 04:01PM Syros to Participate in JMP Securities Life Sciences Conference
Jul 25, 2016 06:57AM JMP Securities Starts Syros Pharmaceuticals (SYRS) at Market Outperform
Jul 6, 2016 04:01PM Syros Pharmaceuticals Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
Jun 30, 2016 11:20AM Syros Pharmaceuticals (SYRS) IPO Opens Up 20%
Jun 30, 2016 06:26AM Syros Pharmaceuticals (SYRS) Prices 4M Common Stock IPO at $12.50/Share, Under Expected Range
Jun 29, 2016 08:34PM Syros Pharmaceuticals Announces Pricing of Initial Public Offering